title: Subthalamic nucleus stimulation improves directly levodopa induced dyskinesias in Parkinson's disease.
authors: R
authors: R
authors: Figueiras-Méndez
authors: F
authors: F
authors: Marín-Zarza
authors: J
authors: J
authors: Antonio Molina
authors: F J
authors: FJ
authors: Jiménez-Jiménez
authors: M
authors: M
authors: Ortí-Pareja
authors: C
authors: C
authors: Magariños
authors: M A
authors: MA
authors: López-Pino
authors: V
authors: V
authors: Martínez
mesh_terms: D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects*; D004599:Electric Stimulation Therapy; D004567:Electrodes, Implanted; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D009069:Movement Disorders / Q000209:etiology* / Q000517:prevention & control*; D010300:Parkinson Disease / Q000188:drug therapy*; D013787:Thalamic Nuclei / Q000601:surgery; D013788:Thalamus / Q000601:surgery
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa